Ep. 381 - FIH urgency in the U.S. Plus: federated learning, biotech IPOs

BioCentury This Week by BioCentury

Pressure is on FDA, policymakers and academic centers in the U.S. to respond to challenges from China, Australia, and beyond to run first in human trials faster and more efficiently. On the latest BioCentury This Week po...View more